Janssen-Cilag AG - Invega 9 mg, Retardtabletten | | 57961 | | 03 | | Invega 9 mg | | Retardtabletten | | N05AX13 | | Paliperidone | | 15.05.2008 | | |
| Composition | paliperidonum 9 mg, polyethyleni oxidum, natrii chloridum corresp. natrium 11.8 mg, povidonum K 29-32, acidum stearicum, E 172 (rubrum), E 321, Überzug: hydroxyethylcellulosum, macrogolum 3350, cellulosi acetas, hypromellosum, macrogolum 400, cera carnauba, E 171, E 172 (rubrum), Drucktinte: hypromellosum, propylenglycolum, E 172 (nigrum), pro compresso obducto. | Packungsbestandteile | | Comprimés retards | | | Principe actif | Concentr. |
---|
Paliperidonum | 9 mg |
| BAG: Principe actif | Concentr. |
---|
Paliperidonum | 9 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Nigrum) | | | (Rubrum) | | | Acidum Stearicum | | | Cellulosi Acetas | | | Cera Carnauba | | | E 171 | | color. | E 172 | | color. | E 321 | | color. | Hydroxyethylcellulosum | | Überzug | Hypromellosum | | Drucktinte | Macrogol | 400 | | Sodium Chlorure | | | Polyethyleni Oxidum | | | Povidonum K | 29-32 | | Pro Compresso Obducto | | | Propylenglycol | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
005 | 28 Comprimé(s) | 171.86 | 202.35 | B | LS | Oui |
|
|